Z

Zai Lab Limited
D

ZLAB

26.430
USD
0.83
(3.24%)
Market Closed
Volume
22,259
EPS
-3
Div Yield
-
P/E
-10
Market Cap
2,858,064,980
OverviewSignalsIdeasNews
Related Instruments
    ADBE
    ADBE
    -26.47
    (-4.99%)
    512.12 USD
    CRWD
    CRWD
    -7.64
    (-2.22%)
    336.77 USD
    MSFT
    MSFT
    -11.75
    (-2.75%)
    417.03 USD
    NVDA
    NVDA
    -4.900
    (-3.34%)
    141.9 USD
    O
    OKTA
    -3.260
    (-4.24%)
    73.660 USD
    PANW
    PANW
    -7.58
    (-1.92%)
    383.25 USD
    S
    SPLK
    0
    (0%)
    0.000000 USD
    TEAM
    TEAM
    -9.960
    (-3.98%)
    240.030 USD
    V
    VEEV
    -16.200
    (-7.06%)
    213.260 USD
    More
News

Title: Zai Lab Limited

Sector: Healthcare
Industry: Biotechnology
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.